PYC Therapeutics Limited

ASX:PYC.AX

0.19 (AUD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 22.05915.80616.0433.0742.39600.0482.7630.0010.8290.7390.7121.9182.3590.5961.2750.0910.27500.053
Cost of Revenue 1.0680.8820.840.6220.5470.1310.0814.6720.1223.5783.6193.267000000.2720.1370
Gross Profit 20.99214.92415.2032.4521.849-0.131-0.033-1.909-0.121-2.749-2.88-2.5551.9182.3590.5961.2750.0910.003-0.1370.053
Gross Profit Ratio 0.9520.9440.9480.7980.7720-0.678-0.691-112.49-3.316-3.895-3.589111110.0101
Reseach & Development Expenses 56.40835.14624.03114.0045.8784.5136.9634.6724.8554.1154.1774.04200002.28401.3760.408
General & Administrative Expenses 4.5084.0916.2987.8293.8181.8281.1631.0380.9040.5410.4341.551.3881.5281.3631.3472.0231.911.5871.258
Selling & Marketing Expenses 0-0.956-0.96-0.622-0.5411.8181.4210.8141.1081.3141.36800000000.020
SG&A 4.5083.1355.3387.2073.2772.4582.7241.8520.9741.8561.8021.551.3881.5281.3631.3472.0231.911.5871.258
Other Expenses 015.75215.9223.1330.06300.0482.7630.0010.0660.0470.7124.5964.5483.8973.630.7840.6050.0340.127
Operating Expenses 60.91738.28129.36821.219.1556.9729.6872.3425.8292.2842.2566.1055.9846.0765.2614.9785.6654.6993.941.793
Operating Income -38.857-39.163-30.208-21.833-9.702-7.102-9.768-4.252-5.951-5.033-5.136-6.105-4.066-3.718-4.664-3.703-5.574-4.696-4.077-1.741
Operating Income Ratio -1.761-2.478-1.883-7.102-4.050-201.571-1.539-5,530.651-6.071-6.946-8.575-2.12-1.576-7.823-2.904-61.418-17.0520-33.125
Total Other Income Expenses Net 0.7470-0.0590.1320.2270.1180.1630.076-0.0950.0750.0860.7120.1620.1130.092-0.8930.7840.605-0.4330.154
Income Before Tax -38.11-39.163-30.267-21.701-9.475-6.984-9.605-4.176-6.046-4.958-5.05-5.319-3.905-3.605-4.573-4.491-4.484-3.889-4.277-1.587
Income Before Tax Ratio -1.728-2.478-1.887-7.059-3.9550-198.201-1.511-5,618.885-5.98-6.829-7.471-2.035-1.529-7.669-3.522-49.409-14.1210-30.203
Income Tax Expense -17.559-15.806-15.973-3.071-2.396-2.904-2.1712.225-2.0671.9661.792-1.8790000.788-0.306-0.202-0.286-1.587
Net Income -37.725-22.789-13.863-17.768-6.822-4.08-7.434-1.951-3.979-2.991-3.258-3.44-3.905-3.605-4.573-4.491-4.484-3.889-3.991-1.587
Net Income Ratio -1.71-1.442-0.864-5.779-2.8480-153.405-0.706-3,697.651-3.608-4.406-4.832-2.035-1.529-7.669-3.522-49.409-14.1210-30.203
EPS -0.01-0.007-0.004-0.006-0.002-0.002-0.003-0.001-0.002-0.001-0.001-0.001-0.001-0.001-0.002-0.002-0.002-0.001-0.001-0.001
EPS Diluted -0.01-0.007-0.004-0.006-0.002-0.002-0.003-0.001-0.002-0.001-0.001-0.001-0.001-0.001-0.002-0.002-0.002-0.001-0.001-0.001
EBITDA -38.118-38.281-29.368-21.21-9.155-6.972-9.687-4.196-5.829-4.821-4.922-5.83-3.87-3.563-4.598-2.696-5.524-4.669-3.592-1.699
EBITDA Ratio -1.728-2.422-1.831-6.899-3.8210-199.894-1.519-5,417.156-5.815-6.657-8.19-2.017-1.511-7.711-2.114-60.873-16.9560-32.32